CORRESP

Pharvaris N.V.

Emmy Noetherweg 2

2333 BK Leiden

The Netherlands

August 15, 2023

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Re:

Pharvaris N.V.

Registration Statement on Form F-3

Filing Date August 7, 2023

File No. 333-273757

REQUEST FOR ACCELERATION OF EFFECTIVENESS

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Pharvaris N.V. (the “Company”) hereby requests acceleration of the effective date of its Registration Statement on Form F-3 (the “Registration Statement”), File No. 333-273757, to 4:30 p.m., Eastern Time, on August 16, 2023, or as soon thereafter as practicable.

Please contact Sophia Hudson of Kirkland & Ellis LLP, special counsel to the Company, at (212) 446-4750 as soon as the Registration Statement has been declared effective, or if you have any other questions or concerns regarding this matter.

 

Sincerely,

/s/ Berndt Modig

Berndt Modig

Chief Executive Officer